Skip to content

BIMATOPROST

CAS 155206-00-1
15

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A prostaglandin analog with significant reproductive and developmental toxicity concerns.

Bimatoprost is a synthetic prostaglandin F2α analog primarily used in ophthalmic solutions for glaucoma and eyelash growth. It carries H302/H312 (acute toxicity), H319 (eye irritation), H340 (genetic defects), H360/H361 (reproductive/developmental toxicity) classifications. It is not listed in EU cosmetic regulation but its pharmaceutical classification and toxicity profile make it unsuitable for cosmetic skincare formulations.

Known concerns

  • Reproductive toxicity (H360/H361)
  • Genetic toxicity concern (H340)
  • Acute oral toxicity (H302)
  • Dermal toxicity (H312)
  • Eye irritation (H319)
  • Pharmaceutical-grade potency

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find BIMATOPROST in your products.

Scan any cosmetic product with LuxSense to see if it contains BIMATOPROST and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.